Global PEG Derivatives Market Insights, Forecast to 2028

PEGs have been shown to provide improved water solubility and biocompatibility in drugs and other applications, and the ability to attach a variety of reactive functional groups to the terminal positions of these polymers has greatly increased their utility. Poly (ethylene glycol) (PEG) is a synthetic, hydrophilic, biocompatible polymer with widespread use in biomedical and other applications. PEGs are synthesized using a ring-opening polymerization of ethylene oxide to produce a broad range of molecular weights and molecular weight distributions (polydispersity); however, discrete PEGs (dPEG®) are synthesized with a single, specific molecular weight. PEGs can be synthesized in linear, branched, Y-shaped, or multi-arm geometries. PEGs can be activated by the replacement of the terminal hydroxyl end group with a variety of reactive functional end groups enabling crosslinking and conjugation chemistries.
Market Analysis and Insights: Global PEG Derivatives Market
Due to the COVID-19 pandemic, the global PEG Derivatives market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Linear PEGs accounting for % of the PEG Derivatives global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical Industry segment is altered to an % CAGR throughout this forecast period.
China PEG Derivatives market size is valued at US$ million in 2021, while the US and Europe PEG Derivatives are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe PEG Derivatives landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of PEG Derivatives include NOF, JenKem Technology, Nektar Therapeutics, Dr. Reddy’s Laboratories, Merck, Chemgen Pharma, SINOPEG, SunBio and Laysan Bio and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the PEG Derivatives capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of PEG Derivatives by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global PEG Derivatives Scope and Segment
PEG Derivatives market is segmented by Type and by Application. Players, stakeholders, and other participants in the global PEG Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Linear PEGs
Branched PEGs
Multi-arm PEGs
Others
Segment by Application
Pharmaceutical Industry
Medical Equipment
Others
By Company
NOF
JenKem Technology
Nektar Therapeutics
Dr. Reddy’s Laboratories
Merck
Chemgen Pharma
SINOPEG
SunBio
Laysan Bio
Creative PEGWorks
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE